A nationwide recall of 17,664 units of the Ciclopirox Shampoo was initiated by the company on December 9, on the grounds that it may lead to temporary or medically reversible health consequences
New FDA draft guidance outlines reduced reliance on primates for monoclonal antibody toxicity testing, aiming to lower costs and accelerate drug development.